What is Aclaris Therapeutics's shares (basic)?

Aclaris Therapeutics (ACRS) reported shares (basic) of 128.8M in Q1 2026.

How has Aclaris Therapeutics's shares (basic) changed year-over-year?

Aclaris Therapeutics's shares (basic) increased by 5.2% year-over-year, from 122.4M to 128.8M.

What is the long-term trend for Aclaris Therapeutics's shares (basic)?

Over 4 years (2021 to 2025), Aclaris Therapeutics's shares (basic) has grown at a 21.9% compound annual growth rate (CAGR), from 222.3M to 490.2M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Aclaris Therapeutics ACRS Shares (Basic)

Shares (Basic) at other companies

IncyteINCY

199.3M+2.9%

Corvus PharmaceuticalsCRVS

90M+24.8%

Upstream Bio, Inc.UPB

54.3M+1.3%

Avalo TherapeuticsAVTX

20.1M+91.2%

Shattuck Labs, Inc.STTK

112.2M+120%

Apogee Therapeutics, Inc.APGE

69.7M+19.7%

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's shares (basic)?: Aclaris Therapeutics (ACRS) reported shares (basic) of 128.8M in Q1 2026.
How has Aclaris Therapeutics's shares (basic) changed year-over-year?: Aclaris Therapeutics's shares (basic) increased by 5.2% year-over-year, from 122.4M to 128.8M.
What is the long-term trend for Aclaris Therapeutics's shares (basic)?: Over 4 years (2021 to 2025), Aclaris Therapeutics's shares (basic) has grown at a 21.9% compound annual growth rate (CAGR), from 222.3M to 490.2M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.